Recently added articles from Advances in Breast Cancer:
Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption.(Report)(Brief article)
Sep 01, 2009; ... Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption Strube A, Hoffmann J, Stepina E et al. Clin Cancer Res, 2009, 15, 3751-3759 Bone metastases are a common problem in human breast cancer, ...
A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.(Report)
Sep 01, 2009; ... A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis Valastyan S, Reinhardt F, Benaich N et al. Cell, 2009, 137, 1032-1046 Since the most devastating consequences of cancer arise from the process of metastatic dissemination, ...
Radiation resistance in breast cancer.(Feature Article)(Report)
Sep 01, 2009; ... Introduction Adjuvant radiotherapy continues to play a key role in the locoregional management of early breast cancer. The 2005 Oxford overview shows a clear benefit from adjuvant locoregional radiotherapy (RT) in reducing long-term 15-year breast cancer mortality [1]. Despite ...
Chemosensitivity (and resistance) in breast cancer.(Feature Article)(Report)
Sep 01, 2009; ... Introduction The medical (non-surgical) management of breast cancer is increasingly complex. The ultimate goal is to deliver the most effective therapies, with the minimum of side effects, to patients who will benefit from them; and none at all to those who do not need them. To ...
Resistance to HER2-directed trastuzumab therapy in breast cancer.(Feature Article)(human Epidermal growth factor receptor 2)(Report)
Sep 01, 2009; ... Background The advent of targeted therapy for cancer has brought about a paradigm shift in the basis of cancer patient management. The approach is principally aimed at providing a tailored drug designed to interact with a molecular target associated with the cancer, as ...